Federated Hermes
AVIR icon

Federated Hermes’s Atea Pharmaceuticals AVIR Stock Holding History

Federated Hermes’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-143
Closed -$769 – 2046
2026
Q1 		$769 Sell
143
-1,159
-89% -$5.32K ﹤0.01% 2016
2025
Q4 		$4.65K Sell
1,302
-2,140
-62% -$6.8K ﹤0.01% 1899
2025
Q3 		$9.98K Hold
3,442
– – ﹤0.01% 1879
2025
Q2 		$12.4K Sell
3,442
-579,287
-99% -$1.73M ﹤0.01% 1788
2025
Q1 		$1.74M Sell
582,729
-210
-0% -$655 ﹤0.01% 972
2024
Q4 		$1.95M Buy
582,939
+10,856
+2% +$36.1K ﹤0.01% 940
2024
Q3 		$1.92M Buy
572,083
+815
+0.1% +$2.96K ﹤0.01% 944
2024
Q2 		$1.89M Sell
571,268
-91
-0% -$339 ﹤0.01% 936
2024
Q1 		$2.31M Sell
571,359
-24,333
-4% -$95.2K 0.01% 896
2023
Q4 		$1.82M Sell
595,692
-13,094
-2% -$39.7K ﹤0.01% 975
2023
Q3 		$1.83M Sell
608,786
-5,204
-0.8% -$17.7K ﹤0.01% 951
2023
Q2 		$2.3M Sell
613,990
-1,425,066
-70% -$5.34M 0.01% 908
2023
Q1 		$6.83M Sell
2,039,056
-1,041,841
-34% -$4.23M 0.02% 633
2022
Q4 		$14.8M Sell
3,080,897
-545,921
-15% -$2.76M 0.04% 448
2022
Q3 		$20.6M Buy
3,626,818
+38,687
+1% +$296K 0.06% 374
2022
Q2 		$25.5M Buy
3,588,131
+1,536,799
+75% +$10.5M 0.07% 332
2022
Q1 		$14.8M Buy
+2,051,332
New +$13.9M 0.03% 514

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Federated Hermes's AVIR Position: Q2 2026 in Review

Federated Hermes sold out of Atea Pharmaceuticals (AVIR) in Q2 2026, closing a stake of 143 shares — an estimated $769 sold.

Federated Hermes first reported a position in AVIR in Q1 2022 and held it in 17 quarters. The position peaked at $25.5M in Q2 2022. 125 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • Federated Hermes reported no remaining Atea Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Federated Hermes sold 143 Atea Pharmaceuticals shares in Q2 2026, an estimated $769.
  • Federated Hermes first reported a position in Atea Pharmaceuticals in Q1 2022 and held it in 17 quarters.
  • Federated Hermes's Atea Pharmaceuticals position peaked at $25.5M in Q2 2022.
  • 125 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.